AHCTF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.905000E-01
Normal-vs-Stage2
5.241200E-01
Normal-vs-Stage3
6.160800E-01
Normal-vs-Stage4
1.461570E-01
Stage1-vs-Stage2
5.510600E-01
Stage1-vs-Stage3
1.271020E-01
Stage1-vs-Stage4
4.203800E-01
Stage2-vs-Stage3
1.754780E-01
Stage2-vs-Stage4
1.449790E-01
Stage3-vs-Stage4
2.780300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.684800E-01
Normal-vs-AfricanAmerican
1.688390E-01
Normal-vs-Asian
7.869600E-01
Caucasian-vs-AfricanAmerican
1.491430E-01
Caucasian-vs-Asian
6.957800E-01
AfricanAmerican-vs-Asian
2.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.420600E-01
Normal-vs-Female
5.450000E-01
Male-vs-Female
9.759800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.228000E-01
Normal-vs-Age(41-60Yrs)
3.320200E-01
Normal-vs-Age(61-80Yrs)
6.546800E-01
Normal-vs-Age(81-100Yrs)
7.339800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.790800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.318400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.954800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.638300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.529000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.119200E-01
Normal-vs-Daily Drinker
7.714200E-01
Normal-vs-Weekly Drinker
5.428400E-01
Normal-vs-Occasional Drinker
2.800600E-01
Normal-vs-Social Drinker
4.526000E-01
Non Drinker-vs-Daily Drinker
8.558000E-02
Non Drinker-vs-Weekly Drinker
6.512000E-01
Non Drinker-vs-Occasional Drinker
3.390800E-01
Non Drinker-vs-Social Drinker
3.810400E-01
Daily Drinker-vs-Weekly Drinker
7.708300E-02
Daily Drinker-vs-Occasional Drinker
8.304700E-03
Daily Drinker-vs-Social Drinker
3.484200E-02
Weekly Drinker-vs-Occasional Drinker
7.568000E-01
Weekly Drinker-vs-Social Drinker
7.443800E-01
Occasional Drinker-vs-Social Drinker
9.100200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.627600E-02
Normal-vs-Grade 2
1.458410E-02
Normal-vs-Grade 3
1.776000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.256000E-02
Grade 1-vs-Grade 3
4.208300E-02
Grade 1-vs-Grade 4
7.627600E-02
Grade 2-vs-Grade 3
4.804600E-01
Grade 2-vs-Grade 4
1.458410E-02
Grade 3-vs-Grade 4
1.776000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.259800E-01
Normal-vs-NonDiabetic
5.522000E-01
Diabetic-vs-NonDiabetic
2.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.257400E-01
Normal-vs-NoPancreatitis
6.107000E-01
Pancreatitis-vs-NoPancreatitis
8.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.729400E-01
Normal-vs-N1
5.530800E-01
N0-vs-N1
5.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.508800E-01
Normal-vs-TP53-NonMutant
5.086000E-01
TP53-Mutant-vs-TP53-NonMutant
5.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
